Cerebral Cavernous Malformation-1 Protein Controls DLL4-Notch3 Signaling between the Endothelium and Pericytes

Stroke

Volumn 46, Issue 5, 2015, Pages 1337-1343

  Schulz, Gerald B ^a   Wieland, Elfriede ^a   Wüstehube Lausch, Joycelyn ^b   Boulday, Gwénola ^c,d   Moll, Iris ^a   Tournier Lasserve, Elisabeth ^c,d,e   Fischer, Andreas ^a,b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c INSERM   (France)

^d UMR S1161   (France)

^e ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

angiogenesis effect; DLL4 protein; Notch3 protein; pericytes

Indexed keywords

CEREBRAL CAVERNOUS MALFORMATION 1 PROTEIN; CEREBRAL CAVERNOUS MALFORMATION 2 PROTEIN; EPHRIN B2; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; MESSENGER RNA; NERVE CELL ADHESION MOLECULE; NOTCH LIGAND DELTA LIKE 4; NOTCH RECEPTOR; NOTCH3 RECEPTOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEOCHONDROITIN SULFATE; REGULATOR PROTEIN; SMOOTH MUSCLE ACTIN; SPHINGOSINE 1 PHOSPHATE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; VASCULOTROPIN A; ACTIN BINDING PROTEIN; DLL4 PROTEIN, MOUSE; KRIT1 PROTEIN, MOUSE; MEMBRANE PROTEIN; MICROTUBULE ASSOCIATED PROTEIN; ONCOPROTEIN; OSMOSENSING SCAFFOLD FOR MEKK3 PROTEIN, MOUSE; SIGNAL PEPTIDE;

ANGIOGENESIS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CAPILLARY ENDOTHELIAL CELL; BRAIN PERICYTE; CAVERNOUS HEMANGIOMA; CELL ADHESION; CELL INTERACTION; CELL INVASION; CELL MIGRATION; COCULTURE; ENDOTHELIUM CELL; GENE CONTROL; GENE EXPRESSION; GENETIC MANIPULATION; HUMAN; HUMAN CELL; MOUSE; NERVE SPROUTING; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL; ANIMAL; BRAIN; BRAIN ARTERIOVENOUS MALFORMATION; CYTOLOGY; GENETICS; PATHOLOGY; PERICYTE; PHYSIOLOGY; PRIMARY CELL CULTURE; TRANSGENIC MOUSE; VASCULAR ENDOTHELIUM;

ANIMALS; BRAIN; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; MEMBRANE PROTEINS; MICE, TRANSGENIC; MICROFILAMENT PROTEINS; MICROTUBULE-ASSOCIATED PROTEINS; PERICYTES; PRIMARY CELL CULTURE; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION;

EID: 84933524147     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.114.007512     Document Type: Article

References (38)

1. Fischer A, Zalvide J, Faurobert E, Albiges-Rizo C, Tournier-Lasserve E. Cerebral cavernous malformations: from CCM genes to endothelial cell homeostasis. Trends Mol Med. 2013;19:302-308. doi: 10.1016/j. molmed.2013.02.004.
2. Labauge P, Denier C, Bergametti F, Tournier-Lasserve E. Genetics of cavernous angiomas. Lancet Neurol. 2007;6:237-244. doi: 10.1016/S1474-4422(07)70053-4.
3. Clatterbuck RE, Eberhart CG, Crain BJ, Rigamonti D. Ultrastructural and immunocytochemical evidence that an incompetent blood-brain barrier is related to the pathophysiology of cavernous malformations. J Neurol Neurosurg Psychiatry. 2001;71:188-192.
4. Tanriover G, Sozen B, Seker A, Kilic T, Gunel M, Demir N. Ultrastructural analysis of vascular features in cerebral cavernous malformations. Clin Neurol Neurosurg. 2013;115:438-444. doi: 10.1016/j. clineuro.2012.06.023.
5. Wong JH, Awad IA, Kim JH. Ultrastructural pathological features of cerebrovascular malformations: a preliminary report. Neurosurgery. 2000;46:1454-1459.
6. Maddaluno L, Rudini N, Cuttano R, Bravi L, Giampietro C, Corada M, et al. EndMT contributes to the onset and progression of cerebral cavernous malformations. Nature. 2013;498:492-496. doi: 10.1038/nature12207.
7. Faurobert E, Rome C, Lisowska J, Manet-Dupé S, Boulday G, Malbouyres M, et al. CCM1-ICAP-1 complex controls 1 integrindependent endothelial contractility and fibronectin remodeling. J Cell Biol. 2013;202:545-561. doi: 10.1083/jcb.201303044.
8. Wüstehube J, Bartol A, Liebler SS, Brütsch R, Zhu Y, Felbor U, et al. Cerebral cavernous malformation protein CCM1 inhibits sprouting angiogenesis by activating DELTA-NOTCH signaling. Proc Natl Acad Sci U S A. 2010;107:12640-12645. doi: 10.1073/pnas.1000132107.
9. You C, Sandalcioglu IE, Dammann P, Felbor U, Sure U, Zhu Y. Loss of CCM3 impairs DLL4-Notch signalling: implication in endothelial angiogenesis and in inherited cerebral cavernous malformations. J Cell Mol Med. 2013;17:407-418. doi: 10.1111/jcmm.12022.
10. Potente M, Gerhardt H, Carmeliet P. Basic and therapeutic aspects of angiogenesis. Cell. 2011;146:873-887. doi: 10.1016/j.cell.2011.08.039.
11. Adam MG, Berger C, Feldner A, Yang WJ, Wüstehube-Lausch J, Herberich SE, et al. Synaptojanin-2 binding protein stabilizes the Notch ligands DLL1 and DLL4 and inhibits sprouting angiogenesis. Circ Res. 2013;113:1206-1218. doi: 10.1161/CIRCRESAHA.113.301686.
12. Jin S, Hansson EM, Tikka S, Lanner F, Sahlgren C, Farnebo F, et al. Notch signaling regulates platelet-derived growth factor receptor-beta expression in vascular smooth muscle cells. Circ Res. 2008;102:1483-1491. doi: 10.1161/CIRCRESAHA.107.167965.
13. Li F, Lan Y, Wang Y, Wang J, Yang G, Meng F, et al. Endothelial Smad4 maintains cerebrovascular integrity by activating N-cadherin through cooperation with Notch. Dev Cell. 2011;20:291-302. doi: 10.1016/j. devcel.2011.01.011.
14. High FA, Lu MM, Pear WS, Loomes KM, Kaestner KH, Epstein JA. Endothelial expression of the Notch ligand Jagged1 is required for vascular smooth muscle development. Proc Natl Acad Sci U S A. 2008;105:1955-1959. doi: 10.1073/pnas.0709663105.
15. Liu H, Kennard S, Lilly B. NOTCH3 expression is induced in mural cells through an autoregulatory loop that requires endothelialexpressed JAGGED1. Circ Res. 2009;104:466-475. doi: 10.1161/CIRCRESAHA.108.184846.
16. Winkler EA, Sengillo JD, Bell RD, Wang J, Zlokovic BV. Blood-spinal cord barrier pericyte reductions contribute to increased capillary permeability. J Cereb Blood Flow Metab. 2012;32:1841-1852. doi: 10.1038/jcbfm.2012.113.
17. Winkler EA, Bell RD, Zlokovic BV. Central nervous system pericytes in health and disease. Nat Neurosci. 2011;14:1398-1405. doi: 10.1038/nn.2946.
18. Hall CN, Reynell C, Gesslein B, Hamilton NB, Mishra A, Sutherland BA, et al. Capillary pericytes regulate cerebral blood flow in health and disease. Nature. 2014;508:55-60. doi: 10.1038/nature13165.
19. Boulday G, Rudini N, Maddaluno L, Blécon A, Arnould M, Gaudric A, et al. Developmental timing of CCM2 loss influences cerebral cavernous malformations in mice. J Exp Med. 2011;208:1835-1847. doi: 10.1084/jem.20110571.
20. Alajati A, Laib AM, Weber H, Boos AM, Bartol A, Ikenberg K, et al. Spheroid-based engineering of a human vasculature in mice. Nat Methods. 2008;5:439-445. doi: 10.1038/nmeth.1198.
21. Laib AM, Bartol A, Alajati A, Korff T, Weber H, Augustin HG. Spheroidbased human endothelial cell microvessel formation in vivo. Nat Protoc. 2009;4:1202-1215. doi: 10.1038/nprot.2009.96.
22. Whitehead KJ, Plummer NW, Adams JA, Marchuk DA, Li DY. Ccm1 is required for arterial morphogenesis: implications for the etiology of human cavernous malformations. Development. 2004;131:1437-1448. doi: 10.1242/dev.01036.
23. Armulik A, Abramsson A, Betsholtz C. Endothelial/pericyte interactions. Circ Res. 2005;97:512-523. doi: 10.1161/01.RES.0000182903.16652. d7.
24. Lampugnani MG, Orsenigo F, Rudini N, Maddaluno L, Boulday G, Chapon F, et al. CCM1 regulates vascular-lumen organization by inducing endothelial polarity. J Cell Sci. 2010;123(pt 7):1073-1080. doi: 10.1242/jcs.059329.
25. Stockton RA, Shenkar R, Awad IA, Ginsberg MH. Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity. J Exp Med. 2010;207:881-896. doi: 10.1084/jem.20091258.
26. Whitehead KJ, Chan AC, Navankasattusas S, Koh W, London NR, Ling J, et al. The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases. Nat Med. 2009;15:177-184. doi: 10.1038/nm.1911.
27. Armulik A, Genové G, Mäe M, Nisancioglu MH, Wallgard E, Niaudet C, et al. Pericytes regulate the blood-brain barrier. Nature. 2010;468:557-561. doi: 10.1038/nature09522.
28. Fernández-Klett F, Offenhauser N, Dirnagl U, Priller J, Lindauer U. Pericytes in capillaries are contractile in vivo, but arterioles mediate functional hyperemia in the mouse brain. Proc Natl Acad Sci U S A. 2010;107:22290-22295. doi: 10.1073/pnas.1011321108.
29. Stewart KS, Zhou Z, Zweidler-McKay P, Kleinerman ES. Delta-like ligand 4-Notch signaling regulates bone marrow-derived pericyte/vascular smooth muscle cell formation. Blood. 2011;117:719-726. doi: 10.1182/blood-2010-05-284869.
30. Schadler KL, Zweidler-McKay PA, Guan H, Kleinerman ES. Delta-like ligand 4 plays a critical role in pericyte/vascular smooth muscle cell formation during vasculogenesis and tumor vessel expansion in Ewing's sarcoma. Clin Cancer Res. 2010;16:848-856. doi: 10.1158/1078-0432. CCR-09-1299.
31. Scehnet JS, Jiang W, Kumar SR, Krasnoperov V, Trindade A, Benedito R, et al. Inhibition of Dll4-mediated signaling induces proliferation of immature vessels and results in poor tissue perfusion. Blood. 2007;109:4753-4760. doi: 10.1182/blood-2006-12-063933.
32. Liu H, Zhang W, Kennard S, Caldwell RB, Lilly B. Notch3 is critical for proper angiogenesis and mural cell investment. Circ Res. 2010;107:860-870. doi: 10.1161/CIRCRESAHA.110.218271.
33. Wang Y, Pan L, Moens CB, Appel B. Notch3 establishes brain vascular integrity by regulating pericyte number. Development. 2014;141:307-317. doi: 10.1242/dev.096107.
34. Hellström M, Kalén M, Lindahl P, Abramsson A, Betsholtz C. Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development. 1999;126:3047-3055.
35. Yildirim O, Bicer A, Ozkan A, Kurtkaya O, Cirakoglu B, Kilic T. Expression of platelet-derived growth factor ligand and receptor in cerebral arteriovenous and cavernous malformations. J Clin Neurosci. 2010;17:1557-1562. doi: 10.1016/j.jocn.2010.04.028.
36. Maiuri F, Cappabianca P, Gangemi M, De Caro Mdel B, Esposito F, Pettinato G, et al. Clinical progression and familial occurrence of cerebral cavernous angiomas: the role of angiogenic and growth factors. Neurosurg Focus. 2006;21:e3.
37. Liu Z, Turkoz A, Jackson EN, Corbo JC, Engelbach JA, Garbow JR, et al. Notch1 loss of heterozygosity causes vascular tumors and lethal hemorrhage in mice. J Clin Invest. 2011;121:800-808. doi: 10.1172/JCI43114.
38. Yan M, Callahan CA, Beyer JC, Allamneni KP, Zhang G, Ridgway JB, et al. Chronic DLL4 blockade induces vascular neoplasms. Nature. 2010;463:E6-E7. doi: 10.1038/nature08751.